Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like Astellas and Universal Cells Ink $124M R&D Pact for Undisclosed Indication October 19, 2017 A Look Inside Takeda's Remarkable R&D Transformation February 26, 2017 <b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec October 10, 2017
<b>Janpix</b> Launches With $22 Million and Will be Helmed by Ex-Boehringer Ingelheim Exec October 10, 2017
